Market Study Report LLC

Plasma Protein Therapeutics Market Will Expand at 6.4% CAGR to Hit 31200 Million USD by 2023

Market Study Report adds 2018-2023 Global Plasma Protein Therapeutics market report that offers an exhaustive coverage of the industry with brief analysis, data charts, figures, statistics that help take business decisions, company profiles and more.


Selbyville, DE -- (SBWIRE) -- 02/28/2019 -- The worldwide market for Plasma Protein Therapeutics is expected to grow at a CAGR of roughly 6.4% over the next five years, will reach 31200 million US$ in 2023, from 21500 million US$ in 2017, according to a new research available with Market Study

Over the last few years, the global plasma protein therapeutics market has experienced rapid development with an average growth rate of 7.1%. As per Report, the global revenue for plasma protein therapeutics market accounted for nearly $20 billion. Plasma protein therapeutics is commonly classified into coagulation factor, albumin, immune globulin, and others. The production revenue of coagulation factor accounted for $3900 million with a revenue market share of 19.5%, while immune globulin's production revenue market share accounted for 50.7% in 2016. The primary use of plasma protein therapeutics is in the treatment of PID, which accounted for 35.5% in 2016.

Request a sample of this premium report at:

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Market Segment by Manufacturers, this report covers:

? Shire (Baxalta)
? Grifols
? Octapharma
? Kedrion
? LFB Group
? Biotest
? Hualan Bio
? Kamada

This report focuses on the Plasma Protein Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Request a discount on standard prices of this premium report at:

Plasma Protein Therapeutics is widely used to treat Hemophilia, PID and Other. The most proportion of Plasma Protein Therapeutics is to treat PID, and the proportion is about 35.5% in 2016.

Market Segment by Type, covers:

? Coagulation Factor
? Immune Globulin
? Albumin
? Other

Market Segment by Applications, can be divided into:

? Hemophilia
? Other

Baxter, CSL, Grifols are the leaders of the industry, with 70% market share in 2016, and hold key technologies and patents. Other manufactures products are used to meet local demand. With further expanding market, there will be more players in the future.

In terms of regional growth, North America is the biggest provider of plasma protein therapeutics, with around 60% revenue market share in 2016. The country is also the largest in sales, with a consumption value market share of 40% in 2016. It also witnesses a large number of exports and is also the largest consumption region.
Meanwhile, Europe prevailed as the second biggest supplier with almost 18.3% revenue market share in 2016. The same year it also procured the second place in sales with a 25.9% market share. In the Asia Pacific region, China emerged as a significant market for Blood Products accounting for a production revenue market share of 9% and sales revenue market share of 14% globally. The competitive landscape of plasma protein therapeutics includes industry leaders like CSL, Baxter, and Grifols that procured 70% market share in 2016 through key technologies and patents, while products of other manufacturers met local demands. However, with continuous expansion of the plasma protein therapeutics market, the industry expects more manufacturers to partake in the market in the future.

Table of Content:

1 Market Overview

2 Manufacturers Profiles

3 Global Plasma Protein Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

4 Global Plasma Protein Therapeutics Market Analysis by Regions

5 North America Plasma Protein Therapeutics by Countries

6 Europe Plasma Protein Therapeutics by Countries

7 Asia-Pacific Plasma Protein Therapeutics by Countries

8 South America Plasma Protein Therapeutics by Countries

9 Middle East and Africa Plasma Protein Therapeutics by Countries

10 Global Plasma Protein Therapeutics Market Segment by Type

11 Global Plasma Protein Therapeutics Market Segment by Application

12 Plasma Protein Therapeutics Market Forecast (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

More Details on this Report at:

Related Reports: -

Global Plasma Protein Therapeutics Market Insights, Forecast to 2025

In 2017, the global Plasma Protein Therapeutics market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Plasma Protein Therapeutics market based on company, product type, application and key regions. This research report categorizes the global Plasma Protein Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Read More:

About Market Study Report allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150